Cover ImageSALE
市場調查報告書

動物用抗菌劑、抗生素的全球市場 (2016∼2020年)

Global Animal Antibacterial and Antibiotics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 379046
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
動物用抗菌劑、抗生素的全球市場 (2016∼2020年) Global Animal Antibacterial and Antibiotics Market 2016-2020
出版日期: 2016年10月19日 內容資訊: 英文 71 Pages
簡介

動物用的抗菌劑、抗生素,用於寵物和家畜 (馬、牛、雞、養殖魚等) 等的疾病治療,還有(尤其是北美、歐洲) 促進成長。可是過度使用那些,使得附藥物抗性的微生物也登場,產生 (透過肉類、牛奶的消費) 引起人畜共通感染疾病的危險性。全球動物用抗菌劑、抗生素市場2016∼2020年以6.5%的年複合成長率成長。

本報告提供全球動物用抗菌劑及抗生素的市場相關分析,產品概要和市場基本結構,法規、認證結構,市場規模趨勢 (今後5年的預測值),各產品種類、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 動物用醫藥品的認證過程

  • NADA (動物用醫藥品核准申請) 與補充事項
  • ANADA (已認證NADA) 與補充事項
  • CNADA (附條件NADA)

第6章 抗菌藥:概要

  • 簡介
  • 作用機制
  • 抗菌藥的使用的基本的原則

第7章 市場環境

  • 市場概要
  • 波特的五力分析

第8章 動物用抗菌劑、抗生素的全球市場:各藥品類型的市場區隔

  • 四環黴素系
  • 其他

第9章 動物用抗菌劑、抗生素的全球市場:地區區分

  • 南北美洲市場
  • 歐洲、中東、非洲各國 (EMEA) 市場
  • 亞太地區市場

第10章 動物用抗菌劑、抗生素的全球市場:推動因素

  • 高蛋白質食品需求
  • 人畜共通感染疾病的患者的增加
  • 家畜飼養頭數的增加

第11章 推動因素的影響力

第12章 動物用抗菌劑、抗生素的全球市場:課題

  • 長期間的法規認證過程
  • 藥物抗性處於的細菌的增加
  • 獸醫醫院的顧客數的減少

第13章 推動因素、課題的影響力

第14章 動物用抗菌劑、抗生素的全球市場:趨勢

  • 產學合作
  • 投資擴大
  • 跟畜產業的一體化

第15章 供應商環境

  • 競爭方案
  • 其他卓越供應商

第16章 主要供應商分析

  • Zoetis
  • Merck Animal Health
  • Merial
  • Elanco
  • Bayer HealthCare

第17章 附錄

  • 簡稱集

第18章 關於Technavio

目錄
Product Code: IRTNTR10637

About Animal Antibacterial and Antibiotics

Antibacterial and antibiotic drugs are used to treat various conditions that affect animals such as companion animals, swine, cattle, horses, and fish. These drugs are also used to accelerate the growth of animals, especially in North America and Europe. However, an overuse of antibiotics has led to the development of antibiotic-resistant strains of microorganisms. This is a worrying trend as the resistant microbes could be transferred to humans through the consumption of milk or meat.

Technavio's analysts forecast the global animal antibacterial and antibiotics market to grow at a CAGR of 6.5% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global animal antibacterial and antibiotics for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Animal Antibacterial and Antibiotics for 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Zoetis
  • Merck Animal Health
  • Merial
  • Elanco
  • Bayer HealthCare

Other Prominent Vendors

  • Animal Medics
  • Biogenesis Bago
  • Bio-Vet
  • Boehringer Ingelheim Vetmedica
  • Ceva Sante Animale
  • Dechra Pharmaceuticals
  • ECO Animal Health
  • Huvepharma, Indian Immunologicals
  • Lillidale Animal Health
  • Mobedco-Vet (The Arab Pesticides & Veterinary Drugs)
  • Neogen
  • Norbrook
  • Orion
  • Phibro Animal Health
  • Vetoquinol
  • Virbac
  • Vitafor

Market driver

  • Demand for protein-rich diet
  • For a full, detailed list, view our report

Market challenge

  • Lengthy regulatory approval process
  • For a full, detailed list, view our report

Market trend

  • Industry-academia collaborations
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Veterinary drug approval process

  • NADAs and supplements
  • ANADAs and supplements
  • CNADAs

PART 06: Antibacterial: Overview

  • Introduction
  • Mechanism of action
  • General principles for the use of antibiotics

PART 07: Market landscape

  • Market overview
  • Five forces analysis

PART 08: Market segmentation by chemical class

  • Tetracyclines
  • Others

PART 09: Geographical segmentation

  • Animal antibacterial and antibiotics market in Americas
  • Animal antibacterial and antibiotics market in EMEA
  • Animal antibacterial and antibiotics market in APAC

PART 10: Market drivers

  • Demand for protein-rich diet
  • Rise in incidences of zoonotic diseases
  • Increase in animal ownership

PART 11: Impact of drivers

PART 12: Market challenges

  • Lengthy regulatory approval process
  • Increase in antibiotic resistance in bacteria
  • Reduced visits to veterinary clinics

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Industry-academia collaborations
  • Increase in investments
  • Vertical integration in livestock industry

PART 15: Vendor landscape

  • Competitive scenario
  • Other prominent vendors

PART 16: Key vendor analysis

  • Zoetis
  • Merck Animal Health
  • Merial
  • Elanco
  • Bayer HealthCare

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Market snapshot: Global animal antibacterial and antibiotics market
  • Exhibit 03: Mechanism of action of antibacterial drugs
  • Exhibit 04: Principles involved in the use of antibiotics
  • Exhibit 05: Overview of global animal antibacterial and antibiotics market
  • Exhibit 06: Factors influencing global animal antibacterial and antibiotics market 2015
  • Exhibit 07: Global animal antibacterial and antibiotics market snapshot: Developed and emerging markets 2015
  • Exhibit 08: Global animal antibacterial and antibiotics market 2015-2020 ($ billions)
  • Exhibit 09: Five forces analysis
  • Exhibit 10: Global animal antibacterial and antibiotics market by chemical class 2015
  • Exhibit 11: Global animal antibacterial and antibiotics market: Segmentation by geography 2015-2020
  • Exhibit 12: Global animal antibacterial and antibiotic market segmentation by region: Market growth lifecycle analysis 2015
  • Exhibit 13: Overview of animal antibacterial and antibiotics market in Americas
  • Exhibit 14: Animal antibacterial and antibiotics market in Americas 2015-2020 ($ billions)
  • Exhibit 15: Animal antibacterial and antibiotics use in Americas
  • Exhibit 16: Overview of animal antibacterial and antibiotics market in EMEA
  • Exhibit 17: Animal antibacterial and antibiotics market in EMEA 2015-2020 ($ billions)
  • Exhibit 18: Animal antibacterial and antibiotics use in EMEA
  • Exhibit 19: Overview of animal antibacterial and antibiotics market in APAC
  • Exhibit 20: Animal antibacterial and antibiotics market in APAC 2015-2020 ($ billions)
  • Exhibit 21: Animal antibacterial and antibiotics use in APAC
  • Exhibit 22: Global animal antibacterial and antibiotics market revenue by geography 2015-2020 ($ billions)
  • Exhibit 23: Impact of drivers and challenges in global animal antibacterial and antibiotics market
  • Exhibit 24: Impact of drivers
  • Exhibit 25: Impact of drivers and challenges
  • Exhibit 26: Impact of trends on global animal antibacterial and antibiotics
  • Exhibit 27: Market ranking of major vendors for global animal antibacterial and antibiotics market
  • Exhibit 28: Geographical presence of key vendors
  • Exhibit 29: Zoetis: Key highlights
  • Exhibit 30: Zoetis: Strength assessment
  • Exhibit 31: Zoetis: Strategy assessment
  • Exhibit 32: Zoetis: Opportunity assessment
  • Exhibit 33: Merck Animal Health: Key highlights
  • Exhibit 34: Merck Animal Health: Strength assessment
  • Exhibit 35: Merck Animal Health: Strategy assessment
  • Exhibit 36: Merck Animal Health: Opportunity assessment
  • Exhibit 37: Merial: Key highlights
  • Exhibit 38: Merial: Strength assessment
  • Exhibit 39: Merial: Strategy assessment
  • Exhibit 40: Merial: Opportunity assessment
  • Exhibit 41: Elanco: Key highlights
  • Exhibit 42: Elanco: Strength assessment
  • Exhibit 43: Elanco: Strategy assessment
  • Exhibit 44: Elanco: Opportunity assessment
  • Exhibit 45: Bayer HealthCare: Key highlights
  • Exhibit 46: Bayer HealthCare: Strength assessment
  • Exhibit 47: Bayer HealthCare: Strategy assessment
  • Exhibit 48: Bayer HealthCare: Opportunity assessment
Back to Top